ID   KCNJ8_HUMAN             Reviewed;         424 AA.
AC   Q15842; O00657;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   10-MAY-2017, entry version 163.
DE   RecName: Full=ATP-sensitive inward rectifier potassium channel 8;
DE   AltName: Full=Inward rectifier K(+) channel Kir6.1;
DE   AltName: Full=Potassium channel, inwardly rectifying subfamily J member 8;
DE   AltName: Full=uKATP-1;
GN   Name=KCNJ8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Lung, and Placenta;
RX   PubMed=8595887; DOI=10.1006/geno.1995.0018;
RA   Inagaki N., Inazawa J., Seino S.;
RT   "cDNA sequence, gene structure, and chromosomal localization of the
RT   human ATP-sensitive potassium channel, uKATP-1, gene (KCNJ8).";
RL   Genomics 30:102-104(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=9573340; DOI=10.1016/S0378-1119(98)00086-9;
RA   Erginel-Unaltuna N., Yang W.P., Blanar M.A.;
RT   "Genomic organization and expression of KCNJ8/Kir6.1, a gene encoding
RT   a subunit of an ATP-sensitive potassium channel.";
RL   Gene 211:71-78(1998).
RN   [4]
RP   REVIEW ON J-WAVE SYNDROMES.
RX   PubMed=20153265; DOI=10.1016/j.hrthm.2009.12.006;
RA   Antzelevitch C., Yan G.X.;
RT   "J wave syndromes.";
RL   Heart Rhythm 7:549-558(2010).
RN   [5]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO J-WAVE SYNDROMES, VARIANT LEU-422,
RP   AND CHARACTERIZATION OF VARIANT LEU-422.
RX   PubMed=20558321; DOI=10.1016/j.hrthm.2010.06.016;
RA   Medeiros-Domingo A., Tan B.H., Crotti L., Tester D.J., Eckhardt L.,
RA   Cuoretti A., Kroboth S.L., Song C., Zhou Q., Kopp D., Schwartz P.J.,
RA   Makielski J.C., Ackerman M.J.;
RT   "Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP)
RT   channel Kir6.1 as a pathogenic substrate for J-wave syndromes.";
RL   Heart Rhythm 7:1466-1471(2010).
RN   [6]
RP   POSSIBLE INVOLVEMENT IN HTOCD, VARIANT HTOCD SER-176, AND
RP   CHARACTERIZATION OF VARIANT HTOCD SER-176.
RX   PubMed=24700710; DOI=10.1002/humu.22555;
RA   Cooper P.E., Reutter H., Woelfle J., Engels H., Grange D.K.,
RA   van Haaften G., van Bon B.W., Hoischen A., Nichols C.G.;
RT   "Cantu syndrome resulting from activating mutation in the KCNJ8
RT   gene.";
RL   Hum. Mutat. 35:809-813(2014).
RN   [7]
RP   VARIANTS SIDS GLU-332 DEL AND ILE-346, AND CHARACTERIZATION OF
RP   VARIANTS SIDS GLU-332 DEL AND ILE-346.
RX   PubMed=21836131; DOI=10.1161/CIRCGENETICS.111.960195;
RA   Tester D.J., Tan B.H., Medeiros-Domingo A., Song C., Makielski J.C.,
RA   Ackerman M.J.;
RT   "Loss-of-function mutations in the KCNJ8-encoded Kir6.1 KATP channel
RT   and sudden infant death syndrome.";
RL   Circ. Cardiovasc. Genet. 4:510-515(2011).
CC   -!- FUNCTION: This potassium channel is controlled by G proteins.
CC       Inward rectifier potassium channels are characterized by a greater
CC       tendency to allow potassium to flow into the cell rather than out
CC       of it. Their voltage dependence is regulated by the concentration
CC       of extracellular potassium; as external potassium is raised, the
CC       voltage range of the channel opening shifts to more positive
CC       voltages. The inward rectification is mainly due to the blockage
CC       of outward current by internal magnesium. Can be blocked by
CC       external barium (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Predominantly detected in fetal and adult
CC       heart. {ECO:0000269|PubMed:9573340}.
CC   -!- DISEASE: Note=Defects in KCNJ8 may be associated with
CC       susceptibility to J-wave syndromes, a group of heart disorders
CC       characterized by early repolarization events as indicated by
CC       abnormal J-wave manifestation on electrocardiogram (ECG). The J
CC       point denotes the junction of the QRS complex and the ST segment
CC       on the ECG, marking the end of depolarization and the beginning of
CC       repolarization. An abnormal J wave is a deflection with a dome or
CC       hump morphology immediately following the QRS complex of the
CC       surface ECG. Examples of J-wave disorders are arrhythmias
CC       associated with an early repolarization pattern in the inferior or
CC       mid to lateral precordial leads, Brugada syndrome, some cases of
CC       idiopathic ventricular fibrillation (VF) with an early
CC       repolarization pattern in the inferior, inferolateral or global
CC       leads, as well as arrhythmias associated with hypothermia.
CC   -!- DISEASE: Sudden infant death syndrome (SIDS) [MIM:272120]: SIDS is
CC       the sudden death of an infant younger than 1 year that remains
CC       unexplained after a thorough case investigation, including
CC       performance of a complete autopsy, examination of the death scene,
CC       and review of clinical history. Pathophysiologic mechanisms for
CC       SIDS may include respiratory dysfunction, cardiac dysrhythmias,
CC       cardiorespiratory instability, and inborn errors of metabolism,
CC       but definitive pathogenic mechanisms precipitating an infant
CC       sudden death remain elusive. {ECO:0000269|PubMed:21836131}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Hypertrichotic osteochondrodysplasia (HTOCD)
CC       [MIM:239850]: A rare disorder characterized by congenital
CC       hypertrichosis, neonatal macrosomia, a distinct
CC       osteochondrodysplasia, and cardiomegaly. The hypertrichosis leads
CC       to thick scalp hair, which extends onto the forehead, and a
CC       general increase in body hair. In addition, macrocephaly and
CC       coarse facial features, including a broad nasal bridge, epicanthal
CC       folds, a wide mouth, and full lips, can be suggestive of a storage
CC       disorder. About half of affected individuals are macrosomic and
CC       edematous at birth, whereas in childhood they usually have a
CC       muscular appearance with little subcutaneous fat. Thickened
CC       calvarium, narrow thorax, wide ribs, flattened or ovoid vertebral
CC       bodies, coxa valga, osteopenia, enlarged medullary canals, and
CC       metaphyseal widening of long bones have been reported. Cardiac
CC       manifestations such as patent ductus arteriosus, ventricular
CC       hypertrophy, pulmonary hypertension, and pericardial effusions are
CC       present in approximately 80% of cases. Motor development is
CC       usually delayed due to hypotonia. Most patients have a mild speech
CC       delay, and a small percentage have learning difficulties or
CC       intellectual disability. {ECO:0000269|PubMed:24700710}. Note=The
CC       disease may be caused by mutations affecting distinct genetic
CC       loci, including the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the inward rectifier-type potassium channel
CC       (TC 1.A.2.1) family. KCNJ8 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D50312; BAA08851.1; -; mRNA.
DR   EMBL; D50315; BAA08852.1; -; Genomic_DNA.
DR   EMBL; BC000544; AAH00544.1; -; mRNA.
DR   CCDS; CCDS8692.1; -.
DR   RefSeq; NP_004973.1; NM_004982.3.
DR   RefSeq; XP_005253415.1; XM_005253358.4.
DR   RefSeq; XP_016874772.1; XM_017019283.1.
DR   RefSeq; XP_016874773.1; XM_017019284.1.
DR   UniGene; Hs.102308; -.
DR   UniGene; Hs.619408; -.
DR   UniGene; Hs.741642; -.
DR   ProteinModelPortal; Q15842; -.
DR   SMR; Q15842; -.
DR   BioGrid; 109966; 19.
DR   STRING; 9606.ENSP00000240662; -.
DR   ChEMBL; CHEMBL4770; -.
DR   DrugBank; DB01251; Gliquidone.
DR   DrugBank; DB01289; Glisoxepide.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB00922; Levosimendan.
DR   DrugBank; DB00914; Phenformin.
DR   DrugBank; DB01154; Thiamylal.
DR   DrugBank; DB01392; Yohimbine.
DR   TCDB; 1.A.2.1.13; inward rectifier k(+) channel (irk-c) family.
DR   iPTMnet; Q15842; -.
DR   PhosphoSitePlus; Q15842; -.
DR   BioMuta; KCNJ8; -.
DR   DMDM; 2493600; -.
DR   EPD; Q15842; -.
DR   PaxDb; Q15842; -.
DR   PeptideAtlas; Q15842; -.
DR   PRIDE; Q15842; -.
DR   DNASU; 3764; -.
DR   Ensembl; ENST00000240662; ENSP00000240662; ENSG00000121361.
DR   GeneID; 3764; -.
DR   KEGG; hsa:3764; -.
DR   UCSC; uc001rff.4; human.
DR   CTD; 3764; -.
DR   DisGeNET; 3764; -.
DR   GeneCards; KCNJ8; -.
DR   HGNC; HGNC:6269; KCNJ8.
DR   HPA; HPA031066; -.
DR   MalaCards; KCNJ8; -.
DR   MIM; 239850; phenotype.
DR   MIM; 272120; phenotype.
DR   MIM; 600935; gene.
DR   neXtProt; NX_Q15842; -.
DR   OpenTargets; ENSG00000121361; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 1517; Hypertrichotic osteochondrodysplasia, Cantu type.
DR   PharmGKB; PA30050; -.
DR   eggNOG; KOG3827; Eukaryota.
DR   eggNOG; ENOG410XQ62; LUCA.
DR   GeneTree; ENSGT00760000118842; -.
DR   HOGENOM; HOG000237325; -.
DR   HOVERGEN; HBG006178; -.
DR   InParanoid; Q15842; -.
DR   KO; K05001; -.
DR   OMA; AMELQCS; -.
DR   OrthoDB; EOG091G08HC; -.
DR   PhylomeDB; Q15842; -.
DR   TreeFam; TF313676; -.
DR   Reactome; R-HSA-1296025; ATP sensitive Potassium channels.
DR   GeneWiki; KCNJ8; -.
DR   GenomeRNAi; 3764; -.
DR   PRO; PR:Q15842; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000121361; -.
DR   CleanEx; HS_KCNJ8; -.
DR   ExpressionAtlas; Q15842; baseline and differential.
DR   Genevisible; Q15842; HS.
DR   GO; GO:0008282; C:ATP-sensitive potassium channel complex; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0030016; C:myofibril; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0015272; F:ATP-activated inward rectifier potassium channel activity; IDA:BHF-UCL.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; TAS:ProtInc.
DR   GO; GO:0017098; F:sulfonylurea receptor binding; IEA:Ensembl.
DR   GO; GO:1902282; F:voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization; IMP:BHF-UCL.
DR   GO; GO:0051607; P:defense response to virus; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0098915; P:membrane repolarization during ventricular cardiac muscle cell action potential; IMP:BHF-UCL.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0006813; P:potassium ion transport; TAS:ProtInc.
DR   GO; GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0009268; P:response to pH; IEA:Ensembl.
DR   GO; GO:0042311; P:vasodilation; IEA:Ensembl.
DR   Gene3D; 2.60.40.1400; -; 1.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR016449; K_chnl_inward-rec_Kir.
DR   InterPro; IPR003278; K_chnl_inward-rec_Kir6.1.
DR   InterPro; IPR013518; K_chnl_inward-rec_Kir_cyto.
DR   PANTHER; PTHR11767; PTHR11767; 1.
DR   PANTHER; PTHR11767:SF75; PTHR11767:SF75; 1.
DR   Pfam; PF01007; IRK; 1.
DR   PIRSF; PIRSF005465; GIRK_kir; 1.
DR   PRINTS; PR01331; KIR61CHANNEL.
DR   PRINTS; PR01320; KIRCHANNEL.
DR   SUPFAM; SSF81296; SSF81296; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Ion channel; Ion transport;
KW   Membrane; Phosphoprotein; Polymorphism; Potassium;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN         1    424       ATP-sensitive inward rectifier potassium
FT                                channel 8.
FT                                /FTId=PRO_0000154947.
FT   TOPO_DOM      1     69       Cytoplasmic. {ECO:0000250}.
FT   TRANSMEM     70     94       Helical; Name=M1. {ECO:0000250}.
FT   TOPO_DOM     95    126       Extracellular. {ECO:0000250}.
FT   INTRAMEM    127    138       Helical; Pore-forming; Name=H5.
FT                                {ECO:0000250}.
FT   INTRAMEM    139    145       Pore-forming. {ECO:0000250}.
FT   TOPO_DOM    146    154       Extracellular. {ECO:0000250}.
FT   TRANSMEM    155    176       Helical; Name=M2. {ECO:0000250}.
FT   TOPO_DOM    177    424       Cytoplasmic. {ECO:0000250}.
FT   MOTIF       140    145       Selectivity filter. {ECO:0000250}.
FT   SITE        170    170       Role in the control of polyamine-mediated
FT                                channel gating and in the blocking by
FT                                intracellular magnesium. {ECO:0000250}.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97794}.
FT   VARIANT     176    176       C -> S (in HTOCD; unknown pathological
FT                                significance; displays gain of function;
FT                                displays reduced ATP sensitivity;
FT                                dbSNP:rs606231264).
FT                                {ECO:0000269|PubMed:24700710}.
FT                                /FTId=VAR_075226.
FT   VARIANT     332    332       Missing (in SIDS; the mutant channel
FT                                displays reduced potassium currents
FT                                compared to wild type).
FT                                {ECO:0000269|PubMed:21836131}.
FT                                /FTId=VAR_065878.
FT   VARIANT     334    334       V -> A (in dbSNP:rs34811413).
FT                                /FTId=VAR_049670.
FT   VARIANT     346    346       V -> I (in SIDS; the mutant channel
FT                                displays reduced potassium currents
FT                                compared to wild type;
FT                                dbSNP:rs147316959).
FT                                {ECO:0000269|PubMed:21836131}.
FT                                /FTId=VAR_065879.
FT   VARIANT     422    422       S -> L (associated with susceptibility to
FT                                J-wave syndromes; the mutant channel
FT                                displays an increase in glibenclamide-
FT                                sensitive potassium currents compared to
FT                                wild type; dbSNP:rs72554071).
FT                                {ECO:0000269|PubMed:20558321}.
FT                                /FTId=VAR_065225.
SQ   SEQUENCE   424 AA;  47968 MW;  973EAA5900C6447C CRC64;
     MLARKSIIPE EYVLARIAAE NLRKPRIRDR LPKARFIAKS GACNLAHKNI REQGRFLQDI
     FTTLVDLKWR HTLVIFTMSF LCSWLLFAIM WWLVAFAHGD IYAYMEKSGM EKSGLESTVC
     VTNVRSFTSA FLFSIEVQVT IGFGGRMMTE ECPLAITVLI LQNIVGLIIN AVMLGCIFMK
     TAQAHRRAET LIFSRHAVIA VRNGKLCFMF RVGDLRKSMI ISASVRIQVV KKTTTPEGEV
     VPIHQLDIPV DNPIESNNIF LVAPLIICHV IDKRSPLYDI SATDLANQDL EVIVILEGVV
     ETTGITTQAR TSYIAEEIQW GHRFVSIVTE EEGVYSVDYS KFGNTVKVAA PRCSARELDE
     KPSILIQTLQ KSELSHQNSL RKRNSMRRNN SMRRNNSIRR NNSSLMVPKV QFMTPEGNQN
     TSES
//
